These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1269 related articles for article (PubMed ID: 33370241)

  • 1. International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function.
    Barnes NM; Ahern GP; Becamel C; Bockaert J; Camilleri M; Chaumont-Dubel S; Claeysen S; Cunningham KA; Fone KC; Gershon M; Di Giovanni G; Goodfellow NM; Halberstadt AL; Hartley RM; Hassaine G; Herrick-Davis K; Hovius R; Lacivita E; Lambe EK; Leopoldo M; Levy FO; Lummis SCR; Marin P; Maroteaux L; McCreary AC; Nelson DL; Neumaier JF; Newman-Tancredi A; Nury H; Roberts A; Roth BL; Roumier A; Sanger GJ; Teitler M; Sharp T; Villalón CM; Vogel H; Watts SW; Hoyer D
    Pharmacol Rev; 2021 Jan; 73(1):310-520. PubMed ID: 33370241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).
    Hoyer D; Clarke DE; Fozard JR; Hartig PR; Martin GR; Mylecharane EJ; Saxena PR; Humphrey PP
    Pharmacol Rev; 1994 Jun; 46(2):157-203. PubMed ID: 7938165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invertebrate serotonin receptors: a molecular perspective on classification and pharmacology.
    Tierney AJ
    J Exp Biol; 2018 Oct; 221(Pt 19):. PubMed ID: 30287590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International Union of Basic and Clinical Pharmacology. CXI. Pharmacology, Signaling, and Physiology of Metabotropic Glutamate Receptors.
    Gregory KJ; Goudet C
    Pharmacol Rev; 2021 Jan; 73(1):521-569. PubMed ID: 33361406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-HT(6) receptor modulators: a patent update. Part 2. Diversity in heterocyclic scaffolds.
    Ivachtchenko AV; Ivanenkov YA; Skorenko AV
    Expert Opin Ther Pat; 2012 Oct; 22(10):1123-68. PubMed ID: 22957857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International Union of Basic and Clinical Pharmacology CXIII: Nuclear Receptor Superfamily-Update 2023.
    Burris TP; de Vera IMS; Cote I; Flaveny CA; Wanninayake US; Chatterjee A; Walker JK; Steinauer N; Zhang J; Coons LA; Korach KS; Cain DW; Hollenberg AN; Webb P; Forrest D; Jetten AM; Edwards DP; Grimm SL; Hartig S; Lange CA; Richer JK; Sartorius CA; Tetel M; Billon C; Elgendy B; Hegazy L; Griffett K; Peinetti N; Burnstein KL; Hughes TS; Sitaula S; Stayrook KR; Culver A; Murray MH; Finck BN; Cidlowski JA
    Pharmacol Rev; 2023 Nov; 75(6):1233-1318. PubMed ID: 37586884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International Union of Basic and Clinical Pharmacology. CXII: Adenosine Receptors: A Further Update.
    IJzerman AP; Jacobson KA; Müller CE; Cronstein BN; Cunha RA
    Pharmacol Rev; 2022 Apr; 74(2):340-372. PubMed ID: 35302044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin pharmacology in the gastrointestinal tract: a review.
    Beattie DT; Smith JA
    Naunyn Schmiedebergs Arch Pharmacol; 2008 May; 377(3):181-203. PubMed ID: 18398601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-hydroxytryptamine: considerations about discovery, receptor classification and relevance to medical research.
    Villalón CM; Terrón JA; Ramírez-San Juan E; Saxena PR
    Arch Med Res; 1995; 26(4):331-44. PubMed ID: 8555727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [5-hydroxytryptamine (serotonin) receptors--nomenclature and classification of types and subtypes].
    Hynie S
    Cesk Fysiol; 1995 Sep; 44(3):135-8. PubMed ID: 7586016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-Hydroxytryptamine receptor "families".
    Schmidt AW; Peroutka SJ
    FASEB J; 1989 Sep; 3(11):2242-9. PubMed ID: 2673898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive dysfunction in neuropsychiatric disorders: selected serotonin receptor subtypes as therapeutic targets.
    Terry AV; Buccafusco JJ; Wilson C
    Behav Brain Res; 2008 Dec; 195(1):30-8. PubMed ID: 18241938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin(7) receptors (5-HT(7)Rs) and their ligands.
    Leopoldo M
    Curr Med Chem; 2004 Mar; 11(5):629-61. PubMed ID: 15032609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developments in 5-hydroxytryptamine receptor pharmacology in migraine.
    Peroutka SJ
    Neurol Clin; 1990 Nov; 8(4):829-39. PubMed ID: 2259314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-hydroxytryptamine (5-HT) receptor ligands.
    Kitson SL
    Curr Pharm Des; 2007; 13(25):2621-37. PubMed ID: 17897004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin receptor ligands and the treatment of obesity.
    Vickers SP; Dourish CT
    Curr Opin Investig Drugs; 2004 Apr; 5(4):377-88. PubMed ID: 15134278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural insight into the serotonin (5-HT) receptor family by molecular docking, molecular dynamics simulation and systems pharmacology analysis.
    Wang YQ; Lin WW; Wu N; Wang SY; Chen MZ; Lin ZH; Xie XQ; Feng ZW
    Acta Pharmacol Sin; 2019 Sep; 40(9):1138-1156. PubMed ID: 30814658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin receptors and therapeutics.
    Launay JM; Callebert J; Bondoux D; Loric S; Maroteaux L
    Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):327-36. PubMed ID: 7522716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor "families" for 5-hydroxytryptamine.
    Peroutka SJ
    J Cardiovasc Pharmacol; 1990; 16 Suppl 3():S8-14. PubMed ID: 1369726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irritable bowel syndrome: new agents targeting serotonin receptor subtypes.
    De Ponti F; Tonini M
    Drugs; 2001; 61(3):317-32. PubMed ID: 11293643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 64.